article thumbnail

What Pharmaceutical Manufacturers Value Most from a Hub

Drug Channels

Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. Nasir discusses how hubs help patients initiate and adhere to drug therapies. Read on for Nasir’s insights.

article thumbnail

Pharma Horizons: Sustainability

European Pharmaceutical Review

Register your details now to download >>> This Pharma Horizons report is brought to you in association with: The post Pharma Horizons: Sustainability appeared first on European Pharmaceutical Review. Interested?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Download for free today!

article thumbnail

GoodRx: Evolving & Expanding Integrated Platform Partnerships to Drive Access, Affordability & Outcomes

Drug Channels

Rick explains why patients and pharmaceutical manufacturers now pay a greater share of prescription costs. He outlines GoodRx's services that address the twin challenges when the patient is the payer and the manufacturer faces intense gross-to-net pressures.

article thumbnail

NOW AVAILABLE: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Drug Channels

Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Click to Enlarge].

article thumbnail

Pharma Horizons: Environmental Monitoring

European Pharmaceutical Review

Download this report to discover key environmental monitoring trends impacting pharmaceutical manufacturers today, including the latest requirements for contamination control, the shift towards rapid methods and the latest regulations on bacterial endotoxin testing. Register your details now to download for free today!

article thumbnail

Nitrosamines analysis with LC/MS-MS

European Pharmaceutical Review

Nitrosamines analysis is, thus, key to ensuring safety and quality in the pharmaceutical industry. Global regulatory bodies now require pharmaceutical manufacturers to control and strive to mitigate the presence of N- nitrosamines in their products.